Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18304
Country/Region: Zambia
Year: 2018
Main Partner: Right to Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $18,905,802 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $4,701,760
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $569,501
Care: Pediatric Care and Support (PDCS) $118,310
Laboratory Infrastructure (HLAB) $696,245
Strategic Information (HVSI) $325,601
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $2,150,552
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Prevention: HIV Testing and Counseling (HVCT) $784,864
Sexual Prevention: Other Sexual Prevention (HVOP) $600,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,091,030
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $4,756,374
Treatment: Pediatric Treatment (PDTX) $2,111,565
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 1-9, Unknown Sex, Negative 2019 436
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 1-9, Unknown Sex, Positive 2019 7
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 10-14, Female, Negative 2019 68
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 10-14, Male, Negative 2019 36
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 15-19, Female, Negative 2019 1,535
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 15-19, Female, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 15-19, Male, Negative 2019 414
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 15-19, Male, Positive 2019 5
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 20-24, Female, Negative 2019 1,362
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 20-24, Female, Positive 2019 30
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 20-24, Male, Negative 2019 822
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 20-24, Male, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 25-29, Female, Negative 2019 786
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 25-29, Female, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 25-29, Male, Negative 2019 847
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 25-29, Male, Positive 2019 14
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 30-34, Female, Negative 2019 786
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 30-34, Female, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 30-34, Male, Negative 2019 847
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 30-34, Male, Positive 2019 14
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 35-39, Female, Negative 2019 786
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 35-39, Female, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 35-39, Male, Negative 2019 847
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 35-39, Male, Positive 2019 14
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 40-49, Female, Negative 2019 786
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 40-49, Female, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 40-49, Male, Negative 2019 847
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 40-49, Male, Positive 2019 14
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 50+, Female, Negative 2019 1,094
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 50+, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 50+, Male, Negative 2019 1,090
HTC_TST_DSD HTS_TST_N_DSD_EW_Age_Sex_Result 50+, Male, Positive 2019 23
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Negative 2019 1,657
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Positive 2019 568
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Negative 2019 1,512
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Positive 2019 849
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Negative 2019 1,647
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Positive 2019 568
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Negative 2019 1,482
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Positive 2019 859
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Negative 2019 1,631
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Positive 2019 556
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Negative 2019 1,452
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Positive 2019 859
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Negative 2019 1,647
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Positive 2019 578
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Negative 2019 1,502
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Positive 2019 859
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Negative 2019 968
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Positive 2019 111
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Negative 2019 1,016
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Positive 2019 135
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Negative 2019 968
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Positive 2019 111
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Negative 2019 1,016
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Positive 2019 135
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Negative 2019 968
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Positive 2019 111
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Negative 2019 1,016
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Positive 2019 135
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Negative 2019 968
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Positive 2019 111
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Negative 2019 1,016
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Positive 2019 135
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Female, Negative 2019 529
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Female, Positive 2019 57
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Male, Negative 2019 593
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Male, Positive 2019 91
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Female, Negative 2019 529
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Female, Positive 2019 57
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Male, Negative 2019 594
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Male, Positive 2019 93
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Female, Negative 2019 529
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Female, Positive 2019 57
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Male, Negative 2019 543
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Male, Positive 2019 81
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Female, Negative 2019 529
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Female, Positive 2019 77
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Male, Negative 2019 543
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Male, Positive 2019 81
HTC_TST_DSD HTS_TST_N_DSD_MN_Age_Sex_Result <5, Unknown Sex, Negative 2019 456
HTC_TST_DSD HTS_TST_N_DSD_MN_Age_Sex_Result <5, Unknown Sex, Positive 2019 109
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Negative 2019 1,603
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Positive 2019 462
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Male, Negative 2019 1,497
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Male, Positive 2019 645
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Negative 2019 1,493
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Positive 2019 486
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Male, Negative 2019 1,467
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Male, Positive 2019 584
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Negative 2019 1,527
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Positive 2019 462
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Male, Negative 2019 1,590
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Male, Positive 2019 522
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Negative 2019 1,473
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Positive 2019 474
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Male, Negative 2019 1,457
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Male, Positive 2019 584
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Negative 2019 11,236
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Positive 2019 894
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Negative 2019 11,258
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Positive 2019 1,716
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Negative 2019 11,236
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Positive 2019 894
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Negative 2019 11,258
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Positive 2019 1,716
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Negative 2019 11,236
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Positive 2019 894
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Negative 2019 11,258
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Positive 2019 1,716
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Negative 2019 11,236
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Positive 2019 894
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Negative 2019 11,258
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Positive 2019 1,716
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Female, Negative 2019 374
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Female, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Male, Negative 2019 416
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Male, Positive 2019 31
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Female, Negative 2019 374
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Female, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Male, Negative 2019 416
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Male, Positive 2019 31
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Female, Negative 2019 374
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Female, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Male, Negative 2019 416
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Male, Positive 2019 31
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Female, Negative 2019 374
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Female, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Male, Negative 2019 416
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Male, Positive 2019 31
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 25-29, Female, Negative 2019 10,151
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 25-29, Female, Positive 2019 436
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 30-34, Female, Negative 2019 7,610
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 30-34, Female, Positive 2019 324
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 35-39, Female, Negative 2019 5,073
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 35-39, Female, Positive 2019 212
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 40-49, Female, Negative 2019 2,536
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 40-49, Female, Positive 2019 101
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 10-14, Female, Negative 2019 86
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 10-14, Female, Positive 2019 22
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 10-14, Male, Negative 2019 61
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 10-14, Male, Positive 2019 4
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Negative 2019 1,727
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Positive 2019 109
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Negative 2019 403
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Positive 2019 22
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Negative 2019 1,308
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Positive 2019 122
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Negative 2019 687
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Positive 2019 129
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Female, Negative 2019 704
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Female, Positive 2019 104
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Male, Negative 2019 735
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Male, Positive 2019 139
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Female, Negative 2019 704
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Female, Positive 2019 104
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Male, Negative 2019 755
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Male, Positive 2019 129
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Female, Negative 2019 704
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Female, Positive 2019 104
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Male, Negative 2019 735
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Male, Positive 2019 129
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Female, Negative 2019 704
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Female, Positive 2019 104
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Male, Negative 2019 735
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Male, Positive 2019 129
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Female, Negative 2019 966
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Female, Positive 2019 131
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Male, Negative 2019 920
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Male, Positive 2019 195
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Female, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Female, Positive 2019 114
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Male, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Male, Positive 2019 151
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Female, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Female, Positive 2019 114
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Male, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Male, Positive 2019 200
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Female, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Female, Positive 2019 114
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Male, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Male, Positive 2019 182
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Female, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Female, Positive 2019 114
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Male, Negative 2019 1,516
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Male, Positive 2019 151
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Negative 2019 11,175
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Positive 2019 833
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Negative 2019 11,937
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Positive 2019 1,207
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Negative 2019 11,252
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Positive 2019 833
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Negative 2019 11,637
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Positive 2019 1,207
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Negative 2019 11,413
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Positive 2019 833
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Negative 2019 11,787
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Positive 2019 1,207
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Negative 2019 11,175
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Positive 2019 833
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Negative 2019 11,637
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Positive 2019 1,207
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 25-29, Male, Negative 2019 3,152
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 25-29, Male, Positive 2019 30
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 30-34, Male, Negative 2019 3,152
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 30-34, Male, Positive 2019 30
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 35-39, Male, Negative 2019 3,152
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 35-39, Male, Positive 2019 30
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 40-49, Male, Negative 2019 3,152
HTC_TST_DSD HTS_TST_N_DSD_VMMC_Age_Sex_Result 40-49, Male, Positive 2019 30
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 742,719
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 3,024
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 189
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 66
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 8
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 237
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 15
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 2,902
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 343
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,016
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 176
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 2,854
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 487
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1,847
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 395
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 1,744
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 744
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 1,592
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 1,187
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 1,285
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 27
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 698
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 19
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 148
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2019 4
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 1,121
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 34
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 277
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 31
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 910
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 112
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 541
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 58
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 716
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 77
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 721
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 90
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 759
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 57
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 205
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 16
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 696
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 26
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 400
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 30
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Female, Negative 2019 541
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Female, Positive 2019 26
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Male, Negative 2019 543
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Male, Positive 2019 28
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 831
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 1-9, Positive 2019 21
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 134
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 10-14, Female, Positive 2019 8
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 72
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 3,283
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 122
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 1,011
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 57
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 3,028
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 227
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 1,516
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 114
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 2,272
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 151
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 2,019
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 151
HTC_TST_DSD Service Delivery Point (Facility) ANC: 10-14, Negative 2019 266
HTC_TST_DSD Service Delivery Point (Facility) ANC: 10-14, Positive 2019 7
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Negative 2019 10,611
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Positive 2019 445
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Negative 2019 14,661
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Positive 2019 624
HTC_TST_DSD Service Delivery Point (Facility) ANC: 50+, Negative 2019 873
HTC_TST_DSD Service Delivery Point (Facility) ANC: 50+, Positive 2019 36
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Negative 2019 2,774
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Positive 2019 185
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 452
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 27
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 247
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 15
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 3,284
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 254
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,178
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 206
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 3,404
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 314
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,806
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 513
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 2,539
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 769
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 1,584
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 1,226
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 5,213
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 99
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 846
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 21
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 461
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 1,978
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 117
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 509
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 45
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,741
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 114
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 1,064
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 36
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 1,382
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 77
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 1,312
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 152
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 32,088
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 781
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 7,033
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 63
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 3,814
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 34
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 24,402
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 408
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 6,170
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 231
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 20,699
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 527
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 11,366
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 847
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 14,649
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 1,204
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 13,900
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 2,068
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2019 10,871
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2019 225
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 2
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 2
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Negative 2019 13,018
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Positive 2019 267
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 2,115
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 50
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 1,170
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 7
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 22,969
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 591
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 6,137
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 196
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 19,612
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 1,168
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 11,759
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 567
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 15,225
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 1,134
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 14,656
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 1,769
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 2,864
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 25
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 15,131
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 154
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 15,235
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 155
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Negative 2019 5,043
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Positive 2019 64
HTS_SELF_DSD HTS_SELF_N_DSD 2019 37,073
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 10-14, Female, Directly-Assisted 2019 365
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 10-14, Female, Unassisted 2019 733
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 10-14, Male, Directly-Assisted 2019 365
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 10-14, Male, Unassisted 2019 733
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Directly-Assisted 2019 1,099
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Unassisted 2019 1,099
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Directly-Assisted 2019 733
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Unassisted 2019 733
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Directly-Assisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Unassisted 2019 1,469
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Directly-Assisted 2019 365
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Unassisted 2019 351
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Directly-Assisted 2019 365
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Unassisted 2019 376
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Directly-Assisted 2019 18,358
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Unassisted 2019 18,715
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Other 2019 4,679
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Self 2019 9,357
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Sex Partner 2019 4,679
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest FSW, Directly-Assisted 2019 11,000
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest FSW, Unassisted 2019 12,509
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest MSM, Directly-Assisted 2019 5,499
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest MSM, Unassisted 2019 7,115
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2019 1,560
PMTCT_ART_DSD New on ART 2019 3,197
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 4,757
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 56,803
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2019 3,801
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2019 956
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 4,757
PMTCT_EID_DSD Sum of Infant Age disaggregates 2019 4,757
PMTCT_STAT_DSD By Age (Denominator): 10-14 2019 81
PMTCT_STAT_DSD By Age (Denominator): 20-24 2019 15,962
PMTCT_STAT_DSD By Age (Denominator): 50+ 2019 19
PMTCT_STAT_DSD By Age (Denominator): <15-19 2019 11,474
PMTCT_STAT_DSD By Age (Numerator): 15-19 2019 81
PMTCT_STAT_DSD By Age (Numerator): 20-24 2019 11,423
PMTCT_STAT_DSD By Number of known positives: 15-19 2019 6
PMTCT_STAT_DSD By Number of known positives: 20-24 2019 302
PMTCT_STAT_DSD By Number of new negative: 15-19 2019 25
PMTCT_STAT_DSD By Number of new negative: 20-24 2019 10,500
PMTCT_STAT_DSD By Number of new positives: 15-19 2019 50
PMTCT_STAT_DSD By Number of new positives: 20-24 2019 621
PMTCT_STAT_DSD Number of new ANC and L&D clients 2019 57,409
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 56,803
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 25-29, Female 2019 12,685
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 30-34, Female 2019 8,594
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 35-39, Female 2019 8,594
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 25-29, Female 2019 15,715
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 30-34, Female 2019 12,566
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 35-39, Female 2019 8,478
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 40-49, Female 2019 8,540
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Known at Entry Positive 2019 429
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Newly Identified Negative 2019 14,669
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Newly Identified Positive 2019 617
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Known at Entry Positive 2019 429
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Newly Identified Negative 2019 11,695
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Newly Identified Positive 2019 442
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Known at Entry Positive 2019 336
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Newly Identified Negative 2019 7,754
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Newly Identified Positive 2019 388
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Known at Entry Positive 2019 58
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Newly Identified Negative 2019 7,403
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Newly Identified Positive 2019 1,079
PrEP_NEW_DSD Female 20-24 2019 72
PrEP_NEW_DSD FSW 2019 251
PrEP_NEW_DSD MSM 2019 56
PrEP_NEW_DSD Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 436
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 25-29, Female 2019 72
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 25-29, Male 2019 130
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 30-34, Female 2019 109
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 30-34, Male 2019 22
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 35-39, Female 2019 22
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 35-39, Male 2019 4
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 40-49, Female 2019 5
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 3
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 2
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 5
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2019 18,825
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2019 12,120
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2019 1,150
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2019 901
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2019 9,153
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2019 9,642
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2019 746
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2019 254
TB_PREV_DSD TB_PREV_D_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, New, Positive 2019 32,996
TB_PREV_DSD TB_PREV_N_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, New, Positive 2019 19,795
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 19,795
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 32,996
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 11
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 11
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 18
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 18
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 31
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2019 31
TX_CURR_DSD Age/Sex: 10-14 Female 2019 1,173
TX_CURR_DSD Age/Sex: 10-14 Male 2019 1,422
TX_CURR_DSD Age/Sex: 15-19 Female 2019 3,513
TX_CURR_DSD Age/Sex: 15-19 Male 2019 1,893
TX_CURR_DSD Age/Sex: 20-24 Female 2019 5,664
TX_CURR_DSD Age/Sex: 20-24 Male 2019 2,464
TX_CURR_DSD Age/Sex: 50+ Female 2019 6,046
TX_CURR_DSD Age/Sex: 50+ Male 2019 5,012
TX_CURR_DSD Age/Sex: <1 2019 1,698
TX_CURR_DSD Age/Sex: <1-9 2019 2,398
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2019 106,391
TX_CURR_DSD Sum of age/sex disaggregates 2019 5,406
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 7,470
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 4,776
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 11,632
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 5,991
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 8,623
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 6,434
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 13,649
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 16,453
TX_NEW_DSD Breastfeeding status 2019 2,496
TX_NEW_DSD By Age/Sex: 1-9 2019 1,010
TX_NEW_DSD By Age/Sex: 10-14 Female 2019 73
TX_NEW_DSD By Age/Sex: 10-14 Male 2019 301
TX_NEW_DSD By Age/Sex: 15-19 Female 2019 431
TX_NEW_DSD By Age/Sex: 15-19 Male 2019 407
TX_NEW_DSD By Age/Sex: 20-24 Female 2019 1,728
TX_NEW_DSD By Age/Sex: 20-24 Male 2019 546
TX_NEW_DSD By Age/Sex: 50+ Female 2019 1,023
TX_NEW_DSD By Age/Sex: 50+ Male 2019 2,698
TX_NEW_DSD By Age/Sex: <1 2019 16
TX_NEW_DSD FSW 2019 96
TX_NEW_DSD MSM 2019 96
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 21,247
TX_NEW_DSD Pregnancy status 2019 1,077
TX_NEW_DSD Sum of Age/Sex disaggregates 2019 7,207
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 1,376
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 568
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 1,985
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 928
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 1,525
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 1,217
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 2,575
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 2,840
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 54,097
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 44,181
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 4,787
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 3,208
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 106,876
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 14,653
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 13,396
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 9,873
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 8,928
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 834
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 793
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 659
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 624
TX_RET_DSD Denominator by Status: Breastfeeding 2019 1,466
TX_RET_DSD Denominator by Status: Pregnant 2019 5,570
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 23,741
TX_RET_DSD Numerator by Status: Breastfeeding 2019 1,342
TX_RET_DSD Numerator by Status: Pregnant 2019 5,091
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 26,019
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2019 4,243
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2019 3,183
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2019 57,312
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2019 41,393
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 106,131
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 106,131
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2019 106,131
TX_TB_DSD TX_TB_D_DSD_TBScreen_NewExistingART_HIV Life-long ART, New, TB Screen - Negative, Positive 2019 106,131
VMMC_CIRC_DSD By Age: 10-14 2019 2,549
VMMC_CIRC_DSD By Age: 15-19 2019 20,391
VMMC_CIRC_DSD By Age: 2 months - 9 years 2019 10
VMMC_CIRC_DSD By Age: 20-24 2019 12,226
VMMC_CIRC_DSD By Age: 25-29 2019 8,154
VMMC_CIRC_DSD By Age: 50+ 2019 508
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2019 50,971
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 50,971
VMMC_CIRC_DSD Sum of age disaggregates (FY15-Current) 2019 43,828
VMMC_CIRC_DSD Sum of age disaggregates (Prior to FY15) 2019 35,674
VMMC_CIRC_DSD VMMC_CIRC_N_DSD_Age_Sex 30-34, Male 2019 2,549
VMMC_CIRC_DSD VMMC_CIRC_N_DSD_Age_Sex 35-39, Male 2019 2,548
VMMC_CIRC_DSD VMMC_CIRC_N_DSD_Age_Sex 40-49, Male 2019 2,036